Contact
Please use this form to send email to PR contact of this press release:
CureVac Announces First Study Participant Enrolled in Phase I Clinical Trial Testing Prophylactic mRNA Rabies Vaccine
TO:
Please use this form to send email to PR contact of this press release:
CureVac Announces First Study Participant Enrolled in Phase I Clinical Trial Testing Prophylactic mRNA Rabies Vaccine
TO: